Infectious complications of CAR T-cell therapy: a clinical update
Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary treatment modality used to treat haematological malignancies. Lymphocytes are engineered to produce CARs directed towards tumour cell antigens. Clinical trials have demonstrated impressive malignancy-related outcomes. Unfortunately, n...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publishing
2021-08-01
|
| Schriftenreihe: | Therapeutic Advances in Infectious Disease |
| Online-Zugang: | https://doi.org/10.1177/20499361211036773 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|